Related references
Note: Only part of the references are listed.Protective effects of PACAP in ischemia
Dora Reglodi et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
Faisal Mohammad Amin et al.
JOURNAL OF HEADACHE AND PAIN (2018)
PACAP and its role in primary headaches
Lars Edvinsson et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients
Song Guo et al.
CEPHALALGIA (2017)
PACAP38: Emerging Drug Target in Migraine and Cluster Headache
Anne Luise Haulund Vollesen et al.
HEADACHE (2017)
Blocking CGRP in migraine patients - a review of pros and cons
Marie Deen et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Chronic changes in pituitary adenylate cyclase-activating polypeptide and related receptors in response to repeated chemical dural stimulation in rats
Xun Han et al.
MOLECULAR PAIN (2017)
Human models of migraine - short-term pain for long-term gain
Messoud Ashina et al.
NATURE REVIEWS NEUROLOGY (2017)
ACUTE AND CHRONIC TRIPTAN EXPOSURE NEITHER ALTERS RODENT CEREBRAL BLOOD FLOW NOR WORSENS ISCHEMIC BRAIN INJURY
Mirko Muzzi et al.
NEUROSCIENCE (2017)
Pituitary adenylate cyclase activating polypeptide (PACAP), stress, and sex hormones
S. Bradley King et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2017)
PACAP/Receptor System in Urinary Bladder Dysfunction and Pelvic Pain Following Urinary Bladder Inflammation or Stress
Beatrice M. Girard et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2017)
Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: comparisons across randomized controlled studies
Dimos D. Mitsikostas et al.
CURRENT OPINION IN NEUROLOGY (2017)
Change in brain network connectivity during PACAP38-induced migraine attacks A resting-state functional MRI study
Faisal Mohammad Amin et al.
NEUROLOGY (2016)
Release of PACAP-38 in episodic cluster headache patients - an exploratory study
Bernadett Tuka et al.
JOURNAL OF HEADACHE AND PAIN (2016)
A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants
Elena Bacchelli et al.
JOURNAL OF HEADACHE AND PAIN (2016)
The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration
A. Vaczy et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
Pituitary adenylate cyclase-activating polypeptide type 1 receptor signaling evokes long-lasting nociceptive behaviors through the activation of spinal astrocytes in mice
Tetsuya Ohnou et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine
Song Guo et al.
PAIN (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Pituitary adenylate cyclase-activating polypeptide expression in peripheral blood mononuclear cells of migraineurs
Lei Hou et al.
CELL AND BIOSCIENCE (2016)
Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier
Sajedeh Eftekhari et al.
BRAIN RESEARCH (2015)
Role of Pituitary Adenylate Cyclase-Activating Polypeptide in Nociception and Migraine
Janos Tajti et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
STIMULATORY EFFECT OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 6-38, M65 AND VASOACTIVE INTESTINAL POLYPEPTIDE 6-28 ON TRIGEMINAL SENSORY NEURONS
E. Saghy et al.
NEUROSCIENCE (2015)
Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine
Simon Akerman et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
THE EFFECTS OF PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE IN RENAL ISCHEMIA/REPERFUSION
Eszter Laszlo et al.
ACTA BIOLOGICA HUNGARICA (2014)
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
Faisal Mohammad Amin et al.
BRAIN (2014)
PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: Possible involvement of mast cells
Deepak K. Bhatt et al.
CEPHALALGIA (2014)
PACAP is essential for the adaptive thermogenic response of brown adipose tissue to cold exposure
Abdoulaye Diane et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Pituitary adenylate cyclase-activating polypeptide (PACAP) in the bed nucleus of the stria terminalis (BNST) increases corticosterone in male and female rats
K. R. Lezak et al.
PSYCHONEUROENDOCRINOLOGY (2014)
Differential Regulatory Role of Pituitary Adenylate Cyclase-Activating Polypeptide in the Serum-Transfer Arthritis Model
Balint Botz et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Pituitary adenylate cyclase activating polypeptide and migraine
Alessandro S. Zagami et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients
Bernadett Tuka et al.
CEPHALALGIA (2013)
Paraventricular Hypothalamic Regulation of Trigeminovascular Mechanisms Involved in Headaches
Claude Robert et al.
JOURNAL OF NEUROSCIENCE (2013)
VIP/PACAP receptors in cerebral arteries of rat: Characterization, localization and relation to intracellular calcium
Andre Erdling et al.
NEUROPEPTIDES (2013)
Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity
Janna Blechman et al.
Frontiers in Endocrinology (2013)
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
Anthony J. Harmar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers
Faisal Mohammad Amin et al.
CEPHALALGIA (2012)
Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38
Michael Baun et al.
CEPHALALGIA (2012)
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Potently Dilates Middle Meningeal Arteries: Implications for Migraine
Arsalan U. Syed et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Multimodal Neuroprotection Induced by PACAP38 in Oxygen-Glucose Deprivation and Middle Cerebral Artery Occlusion Stroke Models
Philip Lazarovici et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Maxadilan, the Lutzomyia longipalpis vasodilator, drives plasma leakage via PAC1-CXCR1/2-pathway
Erik Svensjoe et al.
MICROVASCULAR RESEARCH (2012)
Homeodomain Protein Otp and Activity-Dependent Splicing Modulate Neuronal Adaptation to Stress
Liat Amir-Zilberstein et al.
NEURON (2012)
Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery
Kayi Y. Chan et al.
CEPHALALGIA (2011)
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor
Kerry J. Ressler et al.
NATURE (2011)
PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action
Agnieszka Dejda et al.
PEPTIDES (2011)
Migraine Headache and Ischemic Stroke Risk: An Updated Meta-analysis
June T. Spector et al.
AMERICAN JOURNAL OF MEDICINE (2010)
PACAP38 induces migraine-like attacks in patients with migraine without aura
Henrik Winther Schytz et al.
BRAIN (2009)
The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery
L. J. Boni et al.
CEPHALALGIA (2009)
Pituitary Adenylate Cyclase-Activating Polypeptide Inhibits Food Intake in Mice Through Activation of the Hypothalamic Melanocortin System
Lourdes Mounien et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice
Katalin Sandor et al.
PAIN (2009)
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
D. Vaudry et al.
PHARMACOLOGICAL REVIEWS (2009)
VPAC and PAC receptors: From ligands to function
Louise Dickson et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Migraine and cardiovascular disease: systematic review and meta-analysis
Markus Schuerks et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Role of PACAP in the physiology and pathology of the sympathoadrenal system
Hafida Ghzili et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2008)
Agonistic Behavior of PACAP6-38 on Sensory Nerve Terminals and Cytotrophoblast Cells
D. Reglodi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP
Nicole Nemetz et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 413 cells
Kazunori Kageyama et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Localization, characterization and function of pituitary adenylate cyclase-activating polypeptide during brain development
Jun Watanabe et al.
PEPTIDES (2007)
The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers
Steffen Birk et al.
REGULATORY PEPTIDES (2007)
Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors
Matthias Hautmann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus
L. Mounien et al.
NEUROSCIENCE (2006)
Neuroprotection by endogenous and exogenous PACAP following stroke
Yun Chen et al.
REGULATORY PEPTIDES (2006)
Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles
Sergio Vaccari et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6
Hirokazu Ohtaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells:: Consequences for signaling by VIP and PACAP
EM Lutz et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2006)
Animal models of migraine: looking at the component parts of a complex disorder
A. Bergerot et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retinal degeneration
N Babai et al.
NEUROTOXICITY RESEARCH (2005)
PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone facilitated receptivity in female rats
EM Apostolakis et al.
MOLECULAR ENDOCRINOLOGY (2005)
Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock
C Martínez et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies
M Etminan et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Target areas innervated by PACAP-immunoreactive retinal ganglion cells
J Hannibal et al.
CELL AND TISSUE RESEARCH (2004)
Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells
M Li et al.
ENDOCRINE (2004)
Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain
KM Joo et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Origin of PACAP-immunoreactive nerve fibers innervating the subarachnoidal blood vessels of the rat brain
F Martin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
Changes in light-induced phase shift of circadian rhythm in mice lacking PACAP
C Kawaguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
PACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas -: Evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets
GM Portela-Gomes et al.
REGULATORY PEPTIDES (2003)
Expression patterns of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in the rat placenta
PO Koh et al.
MOLECULAR REPRODUCTION AND DEVELOPMENT (2003)
Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia
D Reglodi et al.
PEPTIDES (2002)
Pituitary adenylate cyclase-activating peptide in the rat central nervous system: An immunohistochemical and in situ hybridization study
J Hannibal
JOURNAL OF COMPARATIVE NEUROLOGY (2002)
Defects in reproductive functions in PACAP-deficient female mice
N Shintani et al.
REGULATORY PEPTIDES (2002)
Characterization of VIP and PACAP receptors in cultured rat penis corpus cavernosum smooth muscle cells and their interaction with guanylate cyclase-B receptors
G Guidone et al.
REGULATORY PEPTIDES (2002)
Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia
M Knutsson et al.
NEUROREPORT (2002)
Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis
C Hamelink et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Differential regulation of pituitary adenylate cyclase-activating peptide receptor variants in the rat suprachiasmatic nucleus
K Shinohara et al.
NEUROSCIENCE (2002)
Pituitary adenylate-cyclase-activating polypeptide expression in the immune system
C Abad et al.
NEUROIMMUNOMODULATION (2002)
Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP)
H Hashimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Role of endogenous PACAP in catecholamine secretion from the rat adrenal gland
Y Fukushima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2001)
Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice
C Otto et al.
JOURNAL OF NEUROSCIENCE (2001)
Dissociation between light-induced phase shift of the circadian rhythm and clock gene expression in mice lacking the pituitary adenylate cyclase activating polypeptide type 1 receptor
J Hannibal et al.
JOURNAL OF NEUROSCIENCE (2001)
Neuropeptide localization in the 'migraine generator' region of the human brainstem
J Tajti et al.
CEPHALALGIA (2001)
Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons
I Tatsuno et al.
BRAIN RESEARCH (2001)
Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat
D Reglodi et al.
STROKE (2000)
PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance
F Jamen et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Immunohistochemical localization and distribution of VIP/PACAP receptors in human lung
R Busto et al.
PEPTIDES (2000)